LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference TranscriptSeeking Alpha • 09/03/25
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of PresbyopiaGlobeNewsWire • 07/31/25
LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 07/30/25
LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of PresbyopiaGlobeNewsWire • 07/28/25
LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 07/16/25
Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect?Zacks Investment Research • 07/15/25
LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in CanadaGlobeNewsWire • 07/07/25
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast AsiaGlobeNewsWire • 05/09/25
LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 05/07/25
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care ConferenceGlobeNewsWire • 05/06/25
LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025GlobeNewsWire • 04/30/25
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 03/19/25
LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025GlobeNewsWire • 03/11/25
Here's Why LENZ Therapeutics, Inc. (LENZ) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 11/18/24